Contract Manufacturing, Sterile, Aseptic Processing

The evolution of CDMOs has led to increased investment in new technologies, capabilities, and expertise.

Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.

Catalent recently held a groundbreaking ceremony at its Bloomington, Indiana pharmaceutical fill/finish site.

Lyophilization Services of New England acquired a sterile injectables manufacturing facility in León, Spain.

CDMO iBio introduced cGMP sterile fill/finish services at its facility in Texas.

Empty and prefilled syringes must pass a range of quality control tests.

The expansion of the CDMO’s Skokie, IL facility includes additional refrigeration and freezer space.

The Pharma Services business of Thermo Fisher Scientific will invest $150 Million at three facilities.

A $100-million investment will expand a range of the CDMO’s service capabilities and offerings.

A monoplant may offer greater supply security and flexibility for specialist medicines.

The company is set to expand biologics and fill/finish capacity at its biologics manufacturing sites in Madison, WI, and Bloomington, IN.

Rentschler Fill Solutions received a certificate of GMP compliance from the Austrian Agency for Health and Food Safety for its new aseptic fill/finish facility.

Vetter chose a winner from four teams that worked for three months to develop ideas for applying digital technology to injectable pharmaceuticals.

The sterile-manufacturing contract development manufacturing organization is approved by FDA for viral vector manufacturing fill/finish processing at its biologics facility in Scotland, UK.

Avara Pharmaceutical Services acquired Sandoz’s sterile manufacturing facility for injectable medicines in Boucherville, Quebec, Canada.

More than 120 healthcare organizations plan to bring competition to generic drug market.

The acquisition is expected to support Emergent BioSolutions’ focus on public health threats and emerging infectious disease.

Vetter anounced the Open Innovation Challenge to examine the applicability of digital trends to injection systems.

Rentschler Fill Solutions and Ultragenyx announce fill and finish agreement for the US commercial supply of Mepsevii.

Rommelag will showcase its blow-fill-seal technology that collectively offers container production, aseptic filling, and container closure.

In adding a Vanrx Pharmasystems aseptic filling isolator, FUJIFILM adds fill/finish for gene therapies and viral vaccines.

Choosing the right contamination control platform requires considerable research into what a product needs for an effective process design.

Grand River Aseptic Manufacturing announces equipment purchase to add vial filling capacity.

The CDMO’s new blow-fill-seal machinery at its Kaysersberg site is now operational.

Grand River Aseptic Manufacturing announces first planned investment in capacity expansion.

Paragon Bioservices will build a new cGMP facility in Maryland and expand its existing cGMP facility at the University of Maryland's BioPark.

The contract research, development, and manufacturing organization has expanded API aseptic manufacturing capacity at its Valladolid, Spain, facility.

A new facility type integrates next-generation mobile cleanroom systems.

Innovation speeds discovery, drives down costs, and improves productivity.

The company has manufactured double-digit number of batches on the new filling line, for use in early-stage clinical trials.